Sichuan Hebang Biotechnology Co Ltd (603077) — Financial Flexibility Index
Sichuan Hebang Biotechnology Co Ltd (603077) has a Financial Flexibility Index of 0.03x as of September 2025. Free cash flow of CN¥366.16 Million (operating CF CN¥165.40 Million minus capex CN¥200.76 Million) represents 0% of total liabilities (CN¥10.53 Billion). Check 603077 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Sichuan Hebang Biotechnology Co Ltd Financial Flexibility Index (2009–2025)
Historical Financial Flexibility Index trend for Sichuan Hebang Biotechnology Co Ltd across 17 annual periods. For the full cash flow conversion analysis, see 603077 cash flow conversion.
Annual Financial Flexibility Index for Sichuan Hebang Biotechnology Co Ltd (2009–2025)
Year-by-year free cash flow to debt coverage for Sichuan Hebang Biotechnology Co Ltd. Explore 603077 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.23x | CN¥2.34 Billion | CN¥1.08 Billion | CN¥10.25 Billion | ▲ +53.1% |
| 2024 | 0.15x | CN¥1.58 Billion | CN¥467.93 Million | CN¥10.64 Billion | ▼ -37.5% |
| 2023 | 0.24x | CN¥1.03 Billion | CN¥200.76 Million | CN¥4.32 Billion | ▼ -71.1% |
| 2022 | 0.83x | CN¥3.58 Billion | CN¥2.64 Billion | CN¥4.34 Billion | ▼ -45.0% |
| 2021 | 1.50x | CN¥4.93 Billion | CN¥3.20 Billion | CN¥3.29 Billion | ▲ +810.5% |
| 2020 | 0.16x | CN¥565.95 Million | CN¥368.85 Million | CN¥3.43 Billion | ▼ -39.5% |
| 2019 | 0.27x | CN¥825.46 Million | CN¥162.92 Million | CN¥3.03 Billion | ▼ -56.5% |
| 2018 | 0.63x | CN¥1.31 Billion | CN¥944.39 Million | CN¥2.09 Billion | ▲ +67.6% |
| 2017 | 0.37x | CN¥685.48 Million | CN¥176.94 Million | CN¥1.83 Billion | ▼ -35.8% |
| 2016 | 0.58x | CN¥1.25 Billion | CN¥575.26 Million | CN¥2.15 Billion | ▲ +70.1% |
| 2015 | 0.34x | CN¥1.58 Billion | CN¥449.20 Million | CN¥4.62 Billion | ▲ +62.7% |
| 2014 | 0.21x | CN¥921.44 Million | CN¥204.67 Million | CN¥4.38 Billion | ▲ +152.4% |
| 2013 | 0.08x | CN¥191.06 Million | CN¥-407.48 Million | CN¥2.29 Billion | ▼ -66.5% |
| 2012 | 0.25x | CN¥408.79 Million | CN¥134.96 Million | CN¥1.64 Billion | ▼ -35.1% |
| 2011 | 0.38x | CN¥897.73 Million | CN¥552.56 Million | CN¥2.34 Billion | ▼ -8.8% |
| 2010 | 0.42x | CN¥901.77 Million | CN¥330.77 Million | CN¥2.14 Billion | ▲ +11.4% |
| 2009 | 0.38x | CN¥917.49 Million | CN¥68.97 Million | CN¥2.43 Billion | — |